RxDoctor Payments Data

Tracy Phelps, MD

Family Medicine · Shelby, NCNPI 1154575801

Payments from drug & device makers

$201in general payments, 2019–2025

Across 10 payments — averaging $20.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Scilex Pharmaceuticals Inc.$53
  • AstraZeneca$48
  • Exact Sciences$30
  • Novo Nordisk$29
  • GSK$23
  • Abbott$18

What the payments were for

  • Food & beverage$201100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$201 in reported general payments places this provider in the 40th percentile of 3,444 family medicine providers in North Carolina.

See all family medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$182,491
Medicare patients
433
Services billed
2,862

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban234$214,562
OzempicSemaglutide168$200,455
FarxigaDapagliflozin Propanediol163$129,895
LinzessLinaclotide105$86,820
Trelegy ElliptaFluticasone/Umeclidin/Vilanter66$60,940
TrulicityDulaglutide34$46,203
Tresiba Flextouch U-100Insulin Degludec40$34,760
JardianceEmpagliflozin36$32,805
Tresiba Flextouch U-200Insulin Degludec27$31,836
MounjaroTirzepatide22$27,719
RybelsusSemaglutide18$23,089
XareltoRivaroxaban24$20,068
WegovySemaglutide15$19,336
Repatha SureclickEvolocumab18$17,889
DapagliflozinDapagliflozin Propanediol18$11,851

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus, Wegovy$29$242,880201 claims
AstraZenecaFarxiga, Symbicort, Breztri Aerosphere$48$147,336200 claims
GSKTrelegy Ellipta, Breo Ellipta$23$67,20977 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 3,444 family medicine providers in North Carolina.

Other family medicine in Shelby

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →